LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
LifeVantage (Nasdaq: LFVN), a leading health and wellness company, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The event is scheduled for September 9-11, 2024 in New York, NY. Steve Fife, President and CEO, and Carl Aure, CFO, will represent the company, meeting with investors and delivering a presentation on Tuesday, September 10, 2024, at approximately 2:00 p.m. Eastern Time.
A live webcast of the presentation will be available on the company's Investor Relations website. The webcast replay will be accessible for about 90 days after the event. This conference participation highlights LifeVantage's commitment to engaging with investors and showcasing its products designed to activate optimal health processes at the cellular level.
LifeVantage (Nasdaq: LFVN), una delle principali aziende nel settore della salute e del benessere, ha annunciato la sua partecipazione al 26° Annual Global Investment Conference di H.C. Wainwright. L'evento è programmato per dal 9 all'11 settembre 2024 a New York, NY. Steve Fife, Presidente e Amministratore Delegato, e Carl Aure, CFO, rappresenteranno l'azienda, incontrando investitori e tenendo una presentazione martedì, 10 settembre 2024, circa le 14:00 (ora orientale).
Una trasmissione in diretta della presentazione sarà disponibile sul sito web delle Relazioni con gli Investitori dell'azienda. La registrazione della trasmissione sarà accessibile per circa 90 giorni dopo l'evento. Questa partecipazione alla conferenza sottolinea l'impegno di LifeVantage nel coinvolgere gli investitori e nel mostrare i suoi prodotti progettati per attivare processi di salute ottimali a livello cellulare.
LifeVantage (Nasdaq: LFVN), una de las principales empresas de salud y bienestar, ha anunciado su participación en la 26ª Conferencia Anual Global de Inversiones de H.C. Wainwright. El evento está programado para del 9 al 11 de septiembre de 2024 en Nueva York, NY. Steve Fife, Presidente y Director Ejecutivo, y Carl Aure, Director Financiero, representarán a la empresa, reunirse con inversores y realizar una presentación el martes 10 de septiembre de 2024, aproximadamente a las 2:00 p.m. hora del este.
Una transmisión en vivo de la presentación estará disponible en el sitio web de Relaciones con Inversores de la empresa. La repetición de la transmisión será accesible durante aproximadamente 90 días después del evento. Esta participación en la conferencia destaca el compromiso de LifeVantage con el compromiso con los inversores y la presentación de sus productos diseñados para activar procesos de salud óptimos a nivel celular.
라이프반타지 (Nasdaq: LFVN), 건강 및 웰빙 분야의 선도 기업,가 H.C. 웨인라이트 제26회 글로벌 투자 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 9월 9일부터 11일까지 뉴욕, NY에서 개최됩니다. 스티브 파이프 CEO와 칼 아우레 CFO가 회사를 대표하며, 투자자들과 만나고 2024년 9월 10일 화요일, 오후 2시경 동부 표준시에 발표를 진행할 예정입니다.
발표의 실시간 웹캐스트는 회사의 투자자 관계 웹사이트에서 제공될 예정입니다. 이 웹캐스트 재방송은 행사 후 약 90일 동안 볼 수 있습니다. 이번 컨퍼런스 참여는 라이프반타지의 투자자와의 교류 의지와 세포 수준에서 최적의 건강 과정을 활성화하도록 설계된 제품을 선보이려는 의지를 강조합니다.
LifeVantage (Nasdaq: LFVN), une entreprise leader dans le domaine de la santé et du bien-être, a annoncé sa participation à la 26ème Conférence Annuelle Mondiale sur les Investissements de H.C. Wainwright. L'événement est prévu du 9 au 11 septembre 2024 à New York, NY. Steve Fife, Président et Directeur Général, et Carl Aure, Directeur Financier, représenteront la société, rencontrant des investisseurs et délivrant une présentation le mardi 10 septembre 2024, vers 14h00, heure de l'Est.
Une retransmission en direct de la présentation sera disponible sur le site web des Relations Investisseurs de l'entreprise. La rediffusion de la présentation sera accessible pendant environ 90 jours après l'événement. Cette participation à la conférence met en avant l'engagement de LifeVantage à interagir avec les investisseurs et à présenter ses produits conçus pour activer des processus de santé optimaux au niveau cellulaire.
LifeVantage (Nasdaq: LFVN), ein führendes Unternehmen im Bereich Gesundheit und Wellness, hat seine Teilnahme an der 26. jährlichen Global Investment Conference von H.C. Wainwright bekannt gegeben. Die Veranstaltung ist vom 9. bis 11. September 2024 in New York, NY, geplant. Steve Fife, Präsident und CEO, sowie Carl Aure, CFO, werden das Unternehmen vertreten, indem sie mit Investoren zusammentreffen und am Dienstag, den 10. September 2024, um etwa 14:00 Uhr Eastern Time eine Präsentation halten.
Eine Live-Übertragung der Präsentation wird auf der Investor Relations-Website des Unternehmens verfügbar sein. Die Wiederholung der Übertragung wird etwa 90 Tage nach der Veranstaltung zugänglich sein. Diese Teilnahme an der Konferenz unterstreicht das Engagement von LifeVantage, mit Investoren zu interagieren und seine Produkte zu präsentieren, die darauf abzielen, optimale Gesundheitsprozesse auf zellulärer Ebene zu aktivieren.
- None.
- None.
SALT LAKE CITY, Sept. 04, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 26th Annual Global Investment Conference, to be held September 9-11, 2024 in New York, NY.
Mr. Fife and Mr. Aure will meet with investors and present at approximately 2:00 p.m. Eastern Time on Tuesday, September 10, 2024. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company’s website.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and probiotics, weight management, and skin and hair care products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+, ProBio, IC Bright®, Daily Wellness, Rise AM, Reset PM, and D3+ dietary supplements, the TrueScience® line of skin and hair care products and Liquid Collagen. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, and Axio®, its nootropic energy drink mixes. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When is LifeVantage (LFVN) participating in the H.C. Wainwright Global Investment Conference?
Who will represent LifeVantage (LFVN) at the H.C. Wainwright conference?
When is LifeVantage's (LFVN) presentation at the H.C. Wainwright conference?
How can investors access LifeVantage's (LFVN) presentation at the H.C. Wainwright conference?
How long will the replay of LifeVantage's (LFVN) presentation be available?
